Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 8, 2009
Patent Application Number
10518110
Date Filed
June 11, 2003
Patent Primary Examiner
Patent abstract
The present invention provides compounds useful for inhibiting the ADAM-10 protein, with selectivity versus MMP-1. Such compounds are useful in the in vitro study of the role of ADAM-10 (and its inhibition) in biological processes. The present invention also comprises pharmaceutical compositions comprising one or more ADAM-10 inhibitors according to the invention in combination with a pharmaceutically acceptable carrier. Such compositions are useful for the treatment of cancer, arthritis, and diseases related to angiogenesis. Correspondingly, the invention also comprises methods of treating forms of cancer, arthritis, and diseases related to angiogenesis in which ADAM-10 plays a critical role.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
